Cleveland Clinic Cancer Advances

Monoclonal Gammopathy of Undetermined Significance (MGUS)

May 18, 2023 Cleveland Clinic Taussig Cancer Institute
Cleveland Clinic Cancer Advances
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Show Notes
Sandra Mazzoni, DO, a hematologist at Cleveland Clinic Taussig Cancer Institute joins the Cancer Advances podcast to talk about monoclonal gammopathy of undetermined significance, known as MGUS. Listen as Dr. Mazzoni talks about this abnormal protein and explains when we can still effectively treat patients before it hits all the criteria for becoming multiple myeloma.